CN102188494B - Medicament for treating high fever of pigs with pure Chinese medicine - Google Patents
Medicament for treating high fever of pigs with pure Chinese medicine Download PDFInfo
- Publication number
- CN102188494B CN102188494B CN2011101123698A CN201110112369A CN102188494B CN 102188494 B CN102188494 B CN 102188494B CN 2011101123698 A CN2011101123698 A CN 2011101123698A CN 201110112369 A CN201110112369 A CN 201110112369A CN 102188494 B CN102188494 B CN 102188494B
- Authority
- CN
- China
- Prior art keywords
- add
- pigs
- parts
- water
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 241000282887 Suidae Species 0.000 title abstract description 10
- 208000021760 high fever Diseases 0.000 title abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 238000002347 injection Methods 0.000 claims abstract description 15
- 239000007924 injection Substances 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 8
- 230000008569 process Effects 0.000 claims abstract description 8
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 3
- 238000001816 cooling Methods 0.000 claims abstract description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 206010020843 Hyperthermia Diseases 0.000 claims description 14
- 230000036031 hyperthermia Effects 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 11
- 230000008021 deposition Effects 0.000 claims description 10
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 8
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 8
- 229960003321 baicalin Drugs 0.000 claims description 8
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 8
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 claims description 7
- JJVGFDTWFVSBIM-UHFFFAOYSA-N Phillyrin Natural products COc1ccc(cc1OC)C2OCC3C2COC3c4ccc(OC)c(OC5OC(CO)C(O)C(O)C5O)c4 JJVGFDTWFVSBIM-UHFFFAOYSA-N 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000003556 assay Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 238000012869 ethanol precipitation Methods 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 238000009413 insulation Methods 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 239000008400 supply water Substances 0.000 claims description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims 2
- 238000004140 cleaning Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 241000700605 Viruses Species 0.000 abstract description 6
- 238000002474 experimental method Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 2
- 206010038743 Restlessness Diseases 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000003322 Coinfection Diseases 0.000 abstract 1
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000010926 purge Methods 0.000 abstract 1
- 238000010791 quenching Methods 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 7
- PASHVRUKOFIRIK-UHFFFAOYSA-L calcium sulfate dihydrate Chemical compound O.O.[Ca+2].[O-]S([O-])(=O)=O PASHVRUKOFIRIK-UHFFFAOYSA-L 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 239000013558 reference substance Substances 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 206010020741 Hyperpyrexia Diseases 0.000 description 4
- 241000282894 Sus scrofa domesticus Species 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000010255 intramuscular injection Methods 0.000 description 4
- 239000007927 intramuscular injection Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229960003722 doxycycline Drugs 0.000 description 3
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 3
- 229960003760 florfenicol Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000001524 infective effect Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010012218 Delirium Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- WMPXPUYPYQKQCX-UHFFFAOYSA-N Sulfamonomethoxine Chemical compound C1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 WMPXPUYPYQKQCX-UHFFFAOYSA-N 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- UDLBSRQHKWDKQA-UHFFFAOYSA-N acetyl acetate;sulfuric acid Chemical compound OS(O)(=O)=O.CC(=O)OC(C)=O UDLBSRQHKWDKQA-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001399 clenbuterol hydrochloride Drugs 0.000 description 1
- OPXKTCUYRHXSBK-UHFFFAOYSA-N clenbuterol hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 OPXKTCUYRHXSBK-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000005571 horizontal transmission Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229950003874 sulfamonomethoxine Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- UURAUHCOJAIIRQ-QGLSALSOSA-N tiamulin Chemical compound CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 UURAUHCOJAIIRQ-QGLSALSOSA-N 0.000 description 1
- 229960004885 tiamulin Drugs 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000005570 vertical transmission Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating high fever of pigs. The medicament is an injection prepared from traditional Chinese medicine materials through extraction, concentration and alcohol precipitation processes in different parts by weight. The pharmaceutical for treating high fever of pigs with pure Chinese medicine is prepared from the following raw materials in parts by weight: 5-16 parts of scutellaria baicalensis, 5-14 parts of fructus forsythiae, 4-13 parts of cornu bubali and 4-13 parts of plaster. Through multiple times of experiments, the traditional Chinese prescription is determined, and the pharmaceutical has good synergistic effect, as well as strong effect on killing bacterium or virus causing the high fever of the pigs, can fast enhance the organism immunity of the pigs and prevent secondary infection and other diseases, with curative ratio of 90.03 percent, is safe and small in toxic and side effects, has no drug resistance, as well as effects of promoting recovery, clearing away heat and drying damp, purging intense heat and detonicating, cooling blood, relieving restlessness and quenching thirsty, removing swelling and dissipating binds through substituting similar medicines, thus being accurate in curative effect.
Description
Technical field
The present invention relates to the veterinary and use medicine, a kind of specifically Chinese medicine medicine of treating porcine hyperthermia.
Background technology
It is one of major industry of China's animal husbandry development that ecological pig produces; Also be a main pillar of China livestock products foreign exchange earning, be aspect increasing national income and uplifting the people's living standard, accelerate the farming and animal husbandry development, adjust the important goal of aspects such as agriculture industrialization structure.Yet, since 2006 by the end of May, the numerous pig farms from south to the north; Pig is bred in growth and part sow, nursery pig have broken out unknown high fever of pigs; The pig sickness rate is suffered from more than 50% in most of morbidity pig farm, and mortality rate has caused serious economy loss for the pig farm and the family of raising pigs up to 50～90%; Some pig farm even therefore go bankrupt, people are with one's hair standing on end once talking " heat ".
" porcine nameless high-fever " is high fever syndrome of pigs, is the equal disease with high of a kind of M & M, mainly occurs in finishing period pig and part sow; The clinical temperature of pig body of 1. falling ill that mainly shows as of sick pig is increased to 40～42.5 ℃; Spirit is depressed, and feed intake descends or appetite is useless cuts off, and trouble Corii Sus domestica skin is rubescent; Behind the ear in one's ear edge cyanosis, abdomen down and health many places skin such as extremity tip the speckle shape is arranged, be aubergine; 2. dyspnea, happiness is lain prostrate, and serious ventral breathing appears in the part pig, and asthma is rapid, and the performance that has is breathed or is irregular breathing; 3. part is suffered from pig rhinorrhea, sneeze, cough, discharge of eye and is increased, and most of pig has the tear speckle, the conjunctivitis symptom occurs; 4. part swinery constipation, feces is constipated, is spherical, yellowish urine and less, muddiness, color burn.The sick pig whole body that the course of disease is long slightly is pale, the anemia phenomenon occurs, and disorderly thick by hair, myasthenia of limbs behind the sick pig of part can not be stood indivedual sick pigs are dying before, and last whole body is twitched and extremely.Morbidity swinery mortality rate is very high, the pig farm that has even up to 50～90%.The part sow miscarriage occurs in later stage of pregnancy (100～110 days), produces stillborn fetus, weak son and mummy.
Its characteristics of incidence is: 1. occur in temperature higher season, the course of disease is long, and generally about 5～20 days, case fatality rate is high; 2. the pig farm to epidemic preventing working think little of, technical staff's idea that keeps healthy is poor, do not have strict sealing pig farm, swinery not to be carried out the pig farm morbidity of health care of system serious; 3. fall ill the body weight of pig generally at 20～80kg, sickness rate is the highest, and the piglet morbidity after the wean is also arranged; 4. medication effect is not ideal, and the pig farm mortality rate of abusing medicine is higher.
The characteristics of porcine hyperthermia " three-hypers one is low " are fever, sickness rate is high, mortality rate is high, cure rate is low.This disease is a kind of height contagious disease, ill pig be the important source of infection of primary disease with malicious pig, main route of transmission is that contact infection, air borne and seminal fluid are propagated, and also can pass through the Placenta Hominis vertical transmission.But number of ways such as susceptible pig per os, nasal cavity, muscle, abdominal cavity, vein and intrauterine inoculation and infective virus, 2-14 week all can be given other susceptible pig with virus disseminating through contact behind the pig infective virus.Flowing of infected pigs also is important circulation way.
Country adopts antibiosis prevention and control usually at present, to the swinery of pig hyperpyrexia is taken place, in feedstuff per ton, adds Florfenicol+sulfamonomethoxine 300 gram/tons; Feedstuff reduces because ill swinery searches for food, and can not absorb the medicine of enough therapeutic doses, and dosing in drinking-water is simultaneously used the effective antibiotics of antibacterial and virus, lets swinery freely drink 5～7 days.Or a pig isolated rearing to having fallen ill; Use sulfamethoxyplridazine class injection to carry out injection for curing; Or with 80% Tiamulin, 125 gram/tons+chlortetracycline 300 gram/tons+ampicillin 200 gram/tons; Or injection florfenicol, doxycycline, ampicillin etc., or cut off the horizontal transmission of disease between piglet and piglet.This cause of disease is responsive to above used chemical drugs, but toxic and side effects is big, and carcinogenic teratogenesis is in various degree arranged.To state of an illness especially severe and the not good sick pig of therapeutic effect, also can only resolutely eliminate.
The Ministry of Agriculture makes the industry standard (NY5029-2001) of " pollution-free food one Carnis Sus domestica ", has stipulated organoleptic indicator, physical and chemical index, microbiological indicator of nuisanceless Carnis Sus domestica etc.It is increasingly high to the appealing of nuisanceless Carnis Sus domestica that " clenbuterol hydrochloride " incident of in March, 2011 exposure just can embody people, so the equal toxic side effect of chemical drugs has very big harm to people's health.The present invention is a Chinese medicine preparation, does not contain any antibiotic, and chemical hormone etc., have no side effect at noresidue, and are safe, are the environmental type preparation.
Summary of the invention
The object of the invention just provides a kind of good effect, short treating period, consumption is few, cost is low, the Chinese medicine preparation medicine of residual few treatment porcine hyperthermia.Is the epoch at center now with back to nature with life sciences, and directional steerings that some developed countries propose from synthetics are sought the medicine of treating in natural Chinese medicinal herb.So we take active action, again through clinical trial for many years, with the prescription of Chinese medicine extraction effective ingredient; Repeatedly small quantities of demonstration test shows according to available data: evident in efficacy, treating both the principal and secondary aspects of a disease, safely, have no side effect noresidue; Meat does not have the melancholy of commodity inspection; Favored by numerous raisers, help improving the physique of the nation people, for vast breeding enterprise escorts.
The present invention is theoretical according to characteristic and the Chinese veterinarian of the antibacterial of physiological property of pig and sufferer pig, virus, from the Chinese prescription worked out, single medicinal material or pharmaceutically active ingredient, carry out in the body, external control test, the best prescription that filters out.
The Chinese medicine preparation of treatment porcine hyperthermia of the present invention, by the raw material of following parts by weight through extracting technological procedure preparation such as embedding: Radix Scutellariae 5-16 part, Fructus Forsythiae 5-14 part, Cornu Bubali 4-13 part, Gypsum Fibrosum 4-13 part.
The side that the present invention treats porcine hyperthermia separates as follows:
Radix Scutellariae: hardship, cold.Return lung, gallbladder, spleen, large intestine, small intestine meridian.Effect: heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive, blood pressure lowering.The fire of the kind eliminating the pathogens from the lung part of the body cavity above the diaphragm housing the heart and lungs of Radix Scutellariae, the fire of the descending large intestine part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels is used for calentura hyperpyrexia excessive thirst, and cough due to lung-heat or intenseness of heat forcing blood are excessive, and disease such as pathopyretic ulcer.Effective ingredient: flavone compound is mainly baicalin (C
21H
18O
11).According to pharmacological research, it has antibacterial action, antifungic action, antivirus action.
Fructus Forsythiae: hardship, be slightly cold, go into the heart, gallbladder meridian.Function: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.Modern pharmacology effect research shows that Fructus Forsythiae has significant inhibitory effect external to multiple pathogen, and antiinflammatory is analgesic, protect the liver the town effect such as tells significantly.
Cornu Bubali: bitter salty, cold.Go into the heart, liver, spleen, stomach four warps.Effect: control epidemic febrile disease intenseness of heat heated, high fever does not move back, unconsciousness and delirium, and the typhoid fever pestilence pathogenic heat attacking blood system in febrile diseases, the clear excess-heat of removing heat from blood, mania and irritation, agitation, delirium, macule, epistaxis, hematochezia, swollen ulcer drug are spitted blood in jaundice.Effective ingredient: cholesterol, aminoacid such as alanine, arginine, aspartic acid, cystine, leucine, tyrosine, serine, valine.
Gypsum Fibrosum: Xin Gan, cold.Effect: clearing heat in QI system divides excess-heat, the epidemic febrile disease hyperpyrexia, and the enhancing human body immunity function, expelling pathogenic factors from muscles for clearing heat, relieving restlessness is quenched the thirst, heat-clearing and toxic substances removing.Effective ingredient: calcium sulphate dihydrate (CaSO
42H
2O).
Fang Yi: we use the Radix Scutellariae heat of losing heart clearly to be monarch drug, the bitter gas that stagnates that looses of Radix Scutellariae, diarrhea due to cold pathogen lung-fire and the cough-relieving of detoxifying, the capable and epistaxis only of forcing blood, " property of medicine opinion ": " can control pyretic toxicity "; " book on Chinese herbal medicine just ": " separating pestilence ", " expectorant promoting the circulation of QI ".Fructus Forsythiae is a ministerial drug, is usually used in epidemic febrile disease heating, hyperpyrexia disease, and agitation, thirsty or send out disease such as macule, clearing heat in QI system, blood system heat.Cornu Bubali, Gypsum Fibrosum are adjuvant among the we.Cornu Bubali, heat-clearing and toxic substances removing, antiviral, antibacterium, enhancing human body immunity function.Control to porcine hyperthermia is superior to most of antibiotics and antiviral drugs.
Take this medicine, through this curable substance porcine hyperthermia of experiment proof in batches, and cure rate is high, and side effect is little, and alternative similar chemical medicine can be prevented and treated porcine hyperthermia, and the meat nonhazardous.
The present invention treats the Chinese medicine preparation of porcine hyperthermia, and commodity are called " pyretic toxicity loses injection ".Use and should invent medicine cure rate 90.03%, effect is obvious.
Toxicity test is treated the present invention the medicine of porcine hyperthermia and is given 40 white mice, injection 2ml medicinal liquid 1kg; Quite 20 times of the pig consumption, the viewing duration animal diet followed is normal, does not see animal dead; After the injection, activity reduces to some extent, but animal survival is in good condition; Recover normal behind the 8h, explain that with this medicine be safe.
The specific embodiment:
[prescription] prescription of the present invention is to clean weighing by following materials of weight proportions: Radix Scutellariae 5-16 part, Fructus Forsythiae 5-14 part, Cornu Bubali 4-13 part, Gypsum Fibrosum 4-13 part.Take by weighing gross weight and be the medical material after proportioning cleans according to the above ratio of 1200g, process the 1000ml injection.
[method for preparing] carried out the strictness screening to each raw material, cleans, and takes by weighing, and by regular pharmaceutical technology rules such as extraction, embedding, sterilizations, produces " pyretic toxicity loses " injection then.Method for making: above four flavors, baikal skullcap root decoction pieces, the decocte with water secondary, each 1 hour, gradation filtered, merging filtrate; Filtrating transfers pH value to 1.0-2.0 with hydrochloric acid (2mol/L), 80 ℃ of insulations 30 minutes, leaves standstill 24 hours, filters, and deposition adds 8 times of water gagings; Stir, transfer PH to 7.0 with 40% sodium hydroxide solution, and add equivalent ethanol, stirring makes molten, filters; Filtrating is transferred PH to 2.0 with hydrochloric acid (2mol/L), and 60 ℃ are incubated 30 minutes, leave standstill 12 hours, filter, and deposition is washed till PH to 4.0 with ethanol; Add 10 times of water gagings, stir, transfer PH to 6.0, add 0.5% active carbon, fully stir with 40% sodium hydroxide solution; 50 ℃ are incubated 30 minutes, add 1 times of amount ethanol and stir, and filter immediately, and filtrating is transferred PH to 2.0 with hydrochloric acid (2mol/L), and 60 ℃ are incubated 30 minutes; Left standstill 12 hours, and filtered, after deposition is washed with small amount of ethanol, in dry, subsequent use below 60 ℃.Cornu Bubali pound sheet is cleaned, and adds 10 times of amounts of water together with rubble cream and decocts secondary, each 7-10 hour, replenishes the moisture that boils off in the decoction process at any time; Collecting decoction adds Fructus Forsythiae, decocte with water three times, each 1 hour, collecting decoction; Filter, be concentrated into relative density and be 1.10-1.15 (70-80 ℃ of survey) and put and be chilled to 40 ℃, add 4% gelatin solution and be stirred to and do not have deposition and produce cold preservation 24 hours; Filter, filtrating is with ethanol precipitation three times, and content is respectively 60%, 75%, 85%, cold preservation is more than 48 hours, filtration; Filtrate recycling ethanol filters to there not being the alcohol flavor, and filtrating is regulated pH value to 7.0 with 40% sodium hydroxide, and is subsequent use.
Get Radix Scutellariae extract, it is an amount of to add water, and heating also makes dissolving with 40% sodium hydroxide accent pH value to 7.0; Add Cornu Bubali, Gypsum Fibrosum, Fructus Forsythiae extracting solution, add water to full dose, add 0.5% active carbon; Keep pH value 7.0, heat little boiling 15 minutes, cooling filters; Supply water for injection to full dose, differentiate baicalin (C
21H
18O
11), phillyrin (C
29H
36O
15) and the qualified back embedding of assay, pH value, sterilization promptly gets.
[character] these article are pale brown color clear liquid.
[discriminating]
(1) gets these article 10ml, put in the water-bath evaporate to dryness residue and add 85% ethanol 5ml and make dissolving, as need testing solution.Other gets the baicalin reference substance, adds 85% ethanol and processes the solution that every 1ml contains 0.1mg, as reference substance solution.According to the thin layer chromatography test, draw above-mentioned solution 1 μ l, put on same polyamide film, be developing solvent with 36% acetic acid, launch, take out, dry, put under the ultra-violet lamp (365nm) and inspect.In the test sample chromatograph, with the corresponding position of reference substance chromatograph on, show the fluorescence speckle of same color.
(2) get these article 4ml, put evaporate to dryness in the water-bath, residue adds methanol 5ml makes dissolving, as need testing solution.Other gets Fructus Forsythiae control medicinal material 0.5g, adds methanol 10ml, and hot dipping 1h filters, and filtrating is as control medicinal material solution.According to thin layer chromatography (appendix VIB) test, draw above-mentioned two kinds of solution 2-5 μ l, put respectively in same be on the silica gel g thin-layer plate of binding agent with the sodium carboxymethyl cellulose; With chloroform-methanol (8: 1) is developing solvent, launches, and takes out; Spray is with acetic anhydride-sulphuric acid (20: 1) solution, in 105 ℃ of bakings several minutes, in the test sample chromatograph; With the corresponding position of control medicinal material chromatograph on, show the speckle of same color.
[inspection] pH value should be 6.0-7.5.
[assay]
(1) the baicalin precision is measured these article 1.5ml and is put in the centrifuge tube, drips 2 of 6mol/L hydrochloric acid solutions, stirs, and promptly separates out deposition; Centrifugal, abandoning supernatant (being sure not to make the deposition loss), deposition adds the about 5ml of 70% ethanol with 5 washings of 0.2mol/L hydrochloric acid solution 1 time; Slight fever makes dissolving, quantitatively changes in the 50ml measuring bottle,, shakes up to scale with 70% ethanol dilution; Precision is measured 1ml, puts in the 25ml measuring bottle, adds the 0.2mol/L hydrochloric acid solution to scale, shakes up; According to spectrophotography, measure trap in the 276nm wavelength, press baicalin (C
21H
18O
11) absorptance (
) be 631 calculating, promptly get.
These article contain baicalin (C
21H
18O
11) every ml must not be lower than 5.0mg
(2) test of phillyrin chromatographic condition and system suitability is a filler with the octadecylsilane chemically bonded silica; With acetonitrile-water (25: 75) is mobile phase; The detection wavelength is 277nm.Number of theoretical plate calculates by the phillyrin peak should be not less than 3000.It is an amount of that the preparation precision of reference substance solution takes by weighing the phillyrin reference substance, adds methanol and process the solution that every 1ml contains 0.2mg, promptly gets.
The about 1g of these article powder is got in the preparation of need testing solution, and accurate the title decides, and puts in the tool plug conical flask, and the accurate methanol 15ml that adds claims to decide weight, and dipping spends the night; Supersound process 25 minutes is put coldly, claims decide weight again, supplies the weight that subtracts mistake with methanol, shakes up filtration; Precision is measured subsequent filtrate 5ml, steams near and does, and adds neutral alumina 0.5g and mixes thoroughly, adds and puts on the neutral alumina post (100-120 order, 1g, internal diameter 1-1.5cm); With 70% ethanol 80ml eluting, collect eluent, be concentrated into driedly, residue is used 50% dissolve with methanol, is transferred in the 5ml measuring bottle; And be diluted to scale, and shake up, filter, get subsequent filtrate, promptly get.
Accurate respectively reference substance solution and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure, and promptly get.
These article contain phillyrin (C
29H
36O
15) every 1ml must not be lower than 0.3mg.
" pyretic toxicity loses injection " and other antibiotic therapy test with the treatment porcine hyperthermia: " pyretic toxicity loses injection " is by every kg body weight 0.05-0.1ml, intramuscular injection logotype 3 days; The every kg body weight of florfenicol is used 20-30mg, and intramuscular injection is 5 days continuously; The every kg body weight of doxycycline is used 10-20mg, and intramuscular injection is 5 days continuously; The every kg body weight of ampicillin is used 25-40mg, and intramuscular injection is 5 days continuously.
Duration of test: test is unified feeding and management with positive pig.
Criterion: clinical symptom disappearance, diet recover normal.
Result of the test
Therapeutic effect compares:
| Divide into groups | The test number | Cure number | The produce effects number | Invalid death | Cure rate |
| Pyretic toxicity loses the injection group | 3250 | 2926 | 324 | 0 | 90.03％ |
| The florfenicol group | 19 | 15 | 2 | 2 | 78.95％ |
| The doxycycline group | 22 | 17 | 2 | 3 | 77.27％ |
| The ampicillin group | 24 | 18 | 3 | 3 | 75％ |
| Matched group | 6 | 1 | 1 | 4 | 17％ |
Clinical experiment disease is bright: experiment effect obviously is superior to other medicines, can substitute other similar drugs, and toxic and side effects is few, and meat does not have the melancholy of commodity inspection, helps improving the overall quality of the population, and helps animal husbandry and develops in a healthy way.
(0027) innovative point:
1, theoretical according to motherland's Chinese medicine, in conjunction with knowledge such as modern Chinese medicine, reasonable compatibility cooperation potentiation is set up prescription and is confirmed most preferred dosage form.
2, based on infective pathogen, directly select medicine, from natural goods, extract active anti-porcine hyperthermia material, with strong points.
3, according to clinical symptoms, from the dynamic change of molecular biology horizontal adjustment body related immune competent cell and cytokine, careful to the basic mechanism of this treatment of diseases, effect is remarkable.
4, through research to pharmacokinetics, selected the dosage form that the most suitable body absorbs, be optimal treatment approach and Therapeutic Method to type.
5, these article are Chinese medicine preparation, do not contain any antibiotic, chemical hormone etc., and noresidue has no side effect, and is safe, is the environmental type preparation.
Claims (1)
1. Chinese medicine medicine of treating porcine hyperthermia, it is characterized in that: it is the injection of being processed by the crude drug component of following portions by weight ratio: Radix Scutellariae 5-16 part, Fructus Forsythiae 5-14 part, Cornu Bubali 4-13 part, Gypsum Fibrosum 4-13 part;
The method for preparing of said injection is: take by weighing gross weight and be the raw medicinal material after the cleaning by above-mentioned ratio of weight and number of 1200g, process the 1000ml injection; Concrete method for making is: above four flavors, and with baikal skullcap root decoction pieces, the decocte with water secondary, each 1 hour, gradation filtered, merging filtrate; Filtrating,, was left standstill 24 hours 80 ℃ of insulations 30 minutes to 1.0-2.0 with the hydrochloric acid adjust pH of 2mol/L, filtered, and precipitated to add 8 times of water gagings; Stir, transfer pH to 7.0 with 40% sodium hydroxide solution, and add equivalent ethanol, stirring makes molten, filters; Filtrating is transferred pH to 2.0 with the hydrochloric acid of 2mol/L, and 60 ℃ are incubated 30 minutes, leave standstill 12 hours, filter, and deposition is washed till pH to 4.0 with ethanol; Add 10 times of water gagings, stir, transfer pH to 6.0, add 0.5% active carbon, fully stir with 40% sodium hydroxide solution; 50 ℃ are incubated 30 minutes, add 1 times of amount ethanol and stir, and filter immediately, and filtrating is transferred pH to 2.0 with the hydrochloric acid of 2mol/L, and 60 ℃ are incubated 30 minutes; Left standstill 12 hours, and filtered, after deposition is washed with small amount of ethanol, in dry, subsequent use below 60 ℃;
Cornu Bubali pound sheet is cleaned, and adds 10 times of amounts of water together with rubble cream and decocts secondary, each 7-10 hour, replenishes the moisture that boils off in the decoction process at any time; Collecting decoction adds Fructus Forsythiae, decocte with water three times, each 1 hour, collecting decoction; Filter, being concentrated into and recording relative density at 70-80 ℃ is 1.10-1.15, puts and is chilled to 40 ℃, adds 4% gelatin solution and is stirred to the generation of nothing deposition, cold preservation 24 hours; Filter, filtrating is with ethanol precipitation three times, and content is respectively 60%, 75%, 85%, cold preservation is more than 48 hours, filtration; Filtrate recycling ethanol filters to there not being the alcohol flavor, and filtrating is regulated pH value to 7.0 with 40% sodium hydroxide, and is subsequent use;
Get Radix Scutellariae extract, it is an amount of to add water, and heating also makes dissolving with 40% sodium hydroxide adjust pH to 7.0; Add the extracting solution of Cornu Bubali, Gypsum Fibrosum, Fructus Forsythiae, add water to full dose, add 0.5% active carbon; Keep pH value 7.0, heat little boiling 15 minutes, cooling filters; Supply water for injection to full dose, baicalin, phillyrin are differentiated and assay, baicalin (C
21H
18O
11) every ml must not be lower than 5.0mg, phillyrin (C
29H
36O
15) every 1ml must not be lower than 0.3mg, pH value should be 6.0-7.5, qualified back embedding, and sterilization promptly gets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101123698A CN102188494B (en) | 2011-05-03 | 2011-05-03 | Medicament for treating high fever of pigs with pure Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101123698A CN102188494B (en) | 2011-05-03 | 2011-05-03 | Medicament for treating high fever of pigs with pure Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102188494A CN102188494A (en) | 2011-09-21 |
| CN102188494B true CN102188494B (en) | 2012-08-22 |
Family
ID=44597929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101123698A Expired - Fee Related CN102188494B (en) | 2011-05-03 | 2011-05-03 | Medicament for treating high fever of pigs with pure Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102188494B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103168957A (en) * | 2012-06-12 | 2013-06-26 | 北京伟嘉人生物技术有限公司 | Animal health feed for preventing hyperthermia of dairy cow |
| CN107551151A (en) * | 2017-09-18 | 2018-01-09 | 颍上庆丰农牧发展有限公司 | It is a kind of to be used to treat parenteral solution of high fever syndrome of pigs and preparation method thereof |
| CN109432287B (en) * | 2018-12-21 | 2021-06-04 | 济南亿民动物药业有限公司 | Traditional Chinese medicine oral liquid for preventing and treating excessive heat syndrome of poultry qi system and preparation method thereof |
| CN110613054A (en) * | 2019-09-17 | 2019-12-27 | 中国农业大学 | Chinese herbal medicine additive for lactating sows and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101156916A (en) * | 2007-09-30 | 2008-04-09 | 中国农业大学 | A medicine for treating hyperpyrexia disease of pig |
| CN101317884A (en) * | 2008-07-08 | 2008-12-10 | 赵志敏 | Medicament for treating interference with respiration diseases of pig |
| CN101721602A (en) * | 2008-10-16 | 2010-06-09 | 岳道友 | Animal remedy for treating porcine nameless high-fever syndrome |
-
2011
- 2011-05-03 CN CN2011101123698A patent/CN102188494B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101156916A (en) * | 2007-09-30 | 2008-04-09 | 中国农业大学 | A medicine for treating hyperpyrexia disease of pig |
| CN101317884A (en) * | 2008-07-08 | 2008-12-10 | 赵志敏 | Medicament for treating interference with respiration diseases of pig |
| CN101721602A (en) * | 2008-10-16 | 2010-06-09 | 岳道友 | Animal remedy for treating porcine nameless high-fever syndrome |
Non-Patent Citations (2)
| Title |
|---|
| 周望平 等.猪高热综合征的防治.《中国畜禽种业》.2007,(第5期),54页. * |
| 邹春生.中西医结合辨证治疗猪无名高热综合征.《中国畜牧兽医》.2008,第35卷(第5期),122-123页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102188494A (en) | 2011-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103006792A (en) | Veterinary drug for preventing livestock bowel diseases, preparation method of drug, and feed | |
| CN102188494B (en) | Medicament for treating high fever of pigs with pure Chinese medicine | |
| CN104208294B (en) | It is a kind of to be used to treat Chinese medicine composition of piglet yellow-white dysentery and preparation method thereof | |
| CN104887890A (en) | Medicine composition for treating white scour of chicken and preparation method thereof | |
| CN102872307A (en) | Traditional Chinese medicine oral liquid for preventing and treating virus diseases of poultry and method for preparing traditional Chinese medicine oral liquid | |
| CN106389562A (en) | Pudilan Xiaoyan granules, preparation method thereof, and product quality control method | |
| CN103768157A (en) | Veterinary antiviral traditional Chinese medicine Ziqi effervescent granules and preparation method thereof | |
| CN107412354B (en) | A veterinary herba Dendrobii granule and its application in chicken necrotic enteritis | |
| CN103652490B (en) | Pig feed for treating blue-eared pig disease and preparation method thereof | |
| CN101244164A (en) | Medicament for preventing and treating hydropsy of pigling | |
| CN102188597B (en) | Medicament of pure traditional Chinese medicine for treating swine enzootic pneumonia | |
| CN106234803A (en) | For treating the feedstuff of piglet pujos blancos | |
| CN103520316B (en) | Traditional Chinese medicine for preventing and treating livestock and poultry diarrhoea and preparation method | |
| CN106389717A (en) | Piglet drug-resistant colibacillosis treating traditional Chinese medicine composition | |
| CN104623068B (en) | Treat medicine of fever in children infantile convulsion and preparation method thereof | |
| CN111588801B (en) | Traditional Chinese medicine dispersible granule for preventing livestock and poultry epidemic diseases and preparation method thereof | |
| CN1833687A (en) | Chinese medicinal compsns. for treating digestive ulcer and chronic gastritis, its prepn. and usage | |
| CN103142702A (en) | Chinese herbal medicine injection liquid for treating porcine reproductive and respiratory syndrome and preparation method thereof | |
| CN100428925C (en) | Preparation of Herba Moslae extract and quality control thereof | |
| CN102258620B (en) | Chinese medicinal injection for treating mixed infection of swine streptococcus and swine fever and preparation method thereof | |
| CN103271983B (en) | A kind of endometritis and colpitic perfusion liquid, its preparation method and application for the treatment of pig | |
| CN101698068A (en) | Medicine for treating high-pathogenicity porcine reproductive and respiratory syndrome | |
| CN1985905A (en) | Chinese medicine preparation for preventing and treating intestinal adhesion after abdominal cavity operation and its preparing process and application | |
| CN106138665A (en) | A kind of Chinese medicine composition for treating chicken pneumonia | |
| CN103610862A (en) | Chinese medicinal herb oral liquid for preventing and treating chicken breathing-type infectious bronchitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhao Zhimin Inventor after: Su Yali Inventor after: Wu Hao Inventor after: Wang Lihui Inventor before: Zhao Zhimin Inventor before: Su Yali Inventor before: Wang Hao Inventor before: Wang Lihui |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHAO ZHIMIN SU YALI WANG HAO WANG LIHUI TO: ZHAO ZHIMIN SU YALI WU HAO WANG LIHUI |
|
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: SU YALI WU HAO WANG LIHUI Effective date: 20130724 Owner name: HEBEI RUIGAO ANIMAL PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHAO ZHIMIN Effective date: 20130724 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100098 HAIDIAN, BEIJING TO: 071200 BAODING, HEBEI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130724 Address after: 071200 in Anguo City of Hebei Province Chinese Medicine Industry Park Patentee after: Hebei ruigao Animal Pharmaceutical Co. Ltd. Address before: 100098 Beijing Dazhong Temple Sun Park 12-603 Patentee before: Zhao Zhimin Patentee before: Su Yali Patentee before: Wu Hao Patentee before: Wang Lihui |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120822 Termination date: 20150503 |
|
| EXPY | Termination of patent right or utility model |